RenewAir – Bonus Content
One thing is universally known three years into the global COVID-19 pandemic: almost all COVID-19 infections occur indoors. Poorly ventilated spaces help spread COVID-19, flu, and other raspatory illnesses. Recognizing the seriousness of the situation, in October 2022, the Biden administration held a White House Summit on Improving Indoor Air Quality. The summit gathered public…
Latest
Articles
RenewAire’s Sustainable Ventilation Solutions
Renewew Air’s sustainable ventilation solution supports the three pillars of sustainability: people, profits, and planet. Indoor air quality significantly impacts health and cognitive function, but Renewew Air’s energy recovery ventilation removes contaminants and improves air quality. In healthcare facilities, ventilation reduces airborne infections and enhances cognitive function. In schools and workplaces, improved air quality boosts…
Articles
DOAS Powers Efficiency, Savings and Healthier Air: Find Out Why and How
Commercial buildings requiring 100% outdoor air to meet ventilation standards and maintain indoor air quality (IAQ) is nothing new in the engineering world. However, the COVID-19 pandemic has brought calls for increased ventilation to further enhance IAQ and improve occupant health, which has brought challenges for traditional HVAC systems. The main responsibility of a 100%…
Latest
ESA Success Requires Strategy, Infrastructure, and Support Beyond Legislation
As education savings accounts (ESAs) gain traction across the United States, the conversation is shifting from policy debates to the complexities of implementation. Fueled by post-pandemic dissatisfaction with traditional school models and a desire for more customizable educational options, ESAs are being adopted in a growing number of states, often under “universal” frameworks. But…
Supply Chain Data Analytics Fails Without Clean Data, Ventagium Delivers the Fix
Supply chain leaders face an overwhelming volume of siloed data across ERPs, TMS platforms, and warehouse systems, yet few know how to align it for smarter decisions. The stakes are rising fast. According to Capgemini’s 2024 report Data: A Powerful Ally in Tackling Scope 3 Emission Reduction Targets, 85% of organizations cite data access…
What’s Next in Preclinical Cancer Immunotherapy Research?
As the field of cancer immunotherapy rapidly evolves, researchers are turning to next-generation in vitro technologies to replicate the complexities of the tumor microenvironment with unprecedented fidelity. Organoid platforms and ex vivo patient-derived tissue models are transforming how scientists approach preclinical testing, offering deeper mechanistic insights and better predictive power for therapeutic response. With immunotherapies…
Analyzing the Suppressive TME in In Vitro Based Assays
In the rapidly advancing field of cancer immunotherapy, accurately modeling the tumor microenvironment (TME) has become essential to improving the predictive power of preclinical drug testing. As immune-modulating therapies surge forward, with over 4,000 immune modulators in development globally, scientists are refining assay technologies that maintain the complexity of patient-specific tumor biology. In vitro platforms…
